Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Ltd. et al
Plaintiff: Azurity Pharmaceuticals, Inc.
Defendant: Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Case Number: 1:2021cv01707
Filed: December 2, 2021
Court: US District Court for the District of Delaware
Presiding Judge: Leonard P Stark
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on December 2, 2021. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 2, 2021 Filing 7 Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. on 12/2/2021.(srs)
December 2, 2021 Filing 6 Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA, Inc. on 12/2/2021. (srs)
December 2, 2021 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc. (srs)
December 2, 2021 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,786,482 B2 ;10,918,621 B2 ;11,040,023 B2. (srs)
December 2, 2021 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 19, 2021. Date of Expiration of Patent: March 25, 2036.Thirty Month Stay Deadline: April 19, 2024. (srs)
December 2, 2021 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs)
December 2, 2021 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3755006.) - filed by Azurity Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(srs)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Ltd. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Azurity Pharmaceuticals, Inc.
Represented By: Jack B. Blumenfeld
Represented By: Megan Elizabeth Dellinger
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma Ltd.
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma USA, Inc.
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?